252 related articles for article (PubMed ID: 11834876)
1. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
3. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
[TBL] [Abstract][Full Text] [Related]
5. Role of plasma renin activity and the renal nerves in the natriuresis of L-NMMA infusion in rats.
Khraibi AA; Ramsey CR; Heublein DM; Berndt TJ; Knox FG
Life Sci; 2001 Jul; 69(10):1123-31. PubMed ID: 11508345
[TBL] [Abstract][Full Text] [Related]
6. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB
Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
8. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
9. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
10. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
[TBL] [Abstract][Full Text] [Related]
11. Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects.
Jacobi J; Schneider MP; John S; Schmieder RE
J Hypertens; 2002 Mar; 20(3):525-30. PubMed ID: 11875321
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
Millar CG; Thiemermann C
Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB
Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
[TBL] [Abstract][Full Text] [Related]
14. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
Hjorth Lassen L; Klingenberg Iversen H; Olesen J
Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
Kvam FI; Ofstad J; Iversen BM
Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417
[TBL] [Abstract][Full Text] [Related]
16. Assessment of endothelial function of the renal vasculature in human subjects.
Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
[TBL] [Abstract][Full Text] [Related]
17. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
Artery; 1998; 23(1):1-9. PubMed ID: 10846613
[TBL] [Abstract][Full Text] [Related]
18. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
19. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K
Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
Dijkhorst-Oei LT; Rabelink TJ; Boer P; Koomans HA
Hypertension; 1997 May; 29(5):1192-8. PubMed ID: 9149686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
